- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | 20/20 Biolabs Inc.: 20/20 BioLabs to Participate in the Maxim Growth Summit 2026 in New York on October 14, 2026 | 1 | GlobeNewswire (USA) | ||
| 02.09. | 20/20 Biolabs, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 19.08. | 20/20 BioLabs Cancer-Test Revenue Jumps 47% As Firefighter Screening Programs Expand | 1 | pulse2.com | ||
| 17.08. | 20/20 Biolabs, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 20/20 BIOLABS Aktie jetzt für 0€ handeln | |||||
| 17.08. | 20/20 Biolabs Q2 GAAP EPS of -$0.26, revenue of $0.73M | 1 | Seeking Alpha | ||
| 17.08. | 20/20 Biolabs Inc.: 20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level | 231 | GlobeNewswire (Europe) | Best Quarter of Flagship Multi-Cancer Early Detection Testing; OneTest Revenue Increased 47% Year-Over-Year to $0.7 Million; Gross Profit Increased 87% to $0.3 Million, with Gross Margin Expanding... ► Artikel lesen | |
| 05.08. | 20/20 Biolabs, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 27.07. | 20/20 BioLabs meets potential partners in East Asia | 1 | Investing.com | ||
| 27.07. | 20/20 Biolabs Inc.: 20/20 BioLabs Participates in BIO Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-Up Strategy | 1 | GlobeNewswire (USA) | ||
| 23.07. | 20/20 Biolabs Inc.: 20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock | 193 | GlobeNewswire (Europe) | Agreement Temporarily Restricts Preferred-to-Common Stock Conversions Below a Defined Price Threshold, Mitigating Potential Near-Term Dilution GAITHERSBURG, Md., July 23, 2026 (GLOBE NEWSWIRE) --... ► Artikel lesen | |
| 22.07. | 20/20 Biolabs, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 09.07. | 20/20 BioLabs reports Q2 MCED revenue to be highest to date | 1 | Investing.com | ||
| 01.07. | 20/20 Biolabs, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 27.05. | 20/20 Biolabs Inc.: 20/20 Biolabs' Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters | 3 | GlobeNewswire (USA) | ||
| 22.05. | 20/20 Biolabs: Pläne für Ebola-Tests treiben Aktie an | 1 | Investing.com Deutsch | ||
| 22.05. | 20/20 Biolabs Inc.: 20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand | 2 | GlobeNewswire (USA) | ||
| 20.05. | 20/20 Biolabs, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 20.05. | 20/20 Biolabs, Inc. GAAP EPS of -$0.28 misses by $0.18, revenue of $0.35M misses by $0.43M | 1 | Seeking Alpha | ||
| 20.05. | 20/20 Biolabs, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.05. | 20/20 Biolabs Inc.: 20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina | 1 | GlobeNewswire (USA) |
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 43,635 | -0,38 % | Fresenius Kabi erhält Warnung von der US-Gesundheitsbehörde FDA | DJ Fresenius Kabi erhält Warnung von der US-Gesundheitsbehörde FDA
DOW JONES--Die Fresenius-Tochter Kabi hat einen Warnschuss von der US-Gesundheitsbehörde FDA erhalten. In dem am Dienstag veröffentlichten... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 37,860 | +0,66 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers mit einem Kursziel von 50 Euro auf "Buy" belassen. Accela sei ein Quantensprung in der Strahlentherapie... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,550 | -0,33 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 11,830 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,27 | +0,03 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| BILLIONTOONE | 105,90 | 0,00 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| HEARTFLOW | 49,270 | -0,10 % | AI Cardiac Diagnostics Pioneer Sets HeartFlow (HTFL) for High-Margin Expansion | ||
| PROCEPT BIOROBOTICS | 17,160 | 0,00 % | PROCEPT BioRobotics Corp - 8-K, Current Report | ||
| ALIGNMENT HEALTHCARE | 7,945 | 0,00 % | Are Options Traders Betting on a Big Move in Alignment Healthcare Stock? | ||
| CARL ZEISS MEDITEC | 31,300 | +0,32 % | 12 Prozent bessere Leistung, 14 Prozent weniger Belastung: Warum ZEISS das Brillenglas neu denkt - und wo Rise Nano Optics ins Spiel kommt | ||
| QTREX QUANTUM | 1,100 | 0,00 % | QTREX Quantum Ltd.: QTREX Interconnect Independently Tested at 20 mK by a Leading Quantum Computing Company; Over 100 dB Channel Isolation, 60 dB Beyond the Market Leader | ||
| GENEDX | 73,03 | -0,08 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| AVEANNA HEALTHCARE | 12,590 | 0,00 % | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | ||
| PROGYNY | 25,220 | 0,00 % | Progyny vor dem Boom?: Wells Fargo sieht bei dieser "Kinderwunsch-Aktie" 42 % Kurspotenzial | © Foto: SOPA Images - Sipa USAWells Fargo traut Progyny 42 Prozent Kurspotenzial zu. Das Geschäft mit Kinderwunsch-Leistungen könnte jetzt zum großen Wachstumstreiber werden Enthaltene Werte: US74340E1038Den... ► Artikel lesen | |
| SANARA MEDTECH | 34,860 | +0,03 % | Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) | FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," "Sanara MedTech," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen |
20/20 BIOLABS INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +2,58 % bei einem Aktienkurs von 0,390 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu 20/20 BIOLABS INC finden Sie auf Wallstreet Online.